3-(Phenylmethoxy)-4-(trifluoromethyl)benzaldehyde, 5g

2-(3,4-Epoxycyclohexyl)-ethyltriethoxysilane, 97%, 500g

8-Methoxy-3,4-dihydro-2H-benzo[b][1,4]oxazine, 97%, 100mg

Tripropylene glycol monomethyl ether, min 97%, for synthesis, 5 l, plastic packaging.

1-[(benzyloxy)carbonyl]-3-hydroxyazetidine-3-carboxylic acid, 95.0%, 250mg

Ethyl 4-bromo-3-ethyl-1-methyl-1H-pyrazole-5-carboxylate, 95+%, 1g

2,2-dimethyl-1-(2-methylpiperazin-1-yl)propan-1-one, 95.0%, 2g

Capsanthin, 98%, 5g

tert-Butyl 2-oxo-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridine-1(2H)-carboxylate, 98%, 5g

N-Methyl-2-morpholinoethanamine, 95.0%, 1g

tert-Butyl ((3R,5S)-5-(hydroxymethyl)pyrrolidin-3-yl)carbamate hydrochloride, 97%, 250mg

2-(4-((3,5-DIFLUOROBENZYL)OXY)PHENYL)-4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLANE, 95%, 100mg

2-Bromo-1-methyl-4-(methylsulfonyl)benzene, 95.0%, 5g